Suppliers / Sichuan Jisheng Biopharmaceutical

Sichuan Jisheng Biopharmaceutical

China Updated 9 July 2026

Sichuan Jisheng Biopharmaceutical is an API manufacturer based in China. It holds 4 active US drug master files across a filed portfolio of 4 molecules.

4
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
China, China 3013639540

What they file, and where

Molecule Regulators Docs
Eptifibatide US FDA 1
Retatrutide US FDA 1
Semaglutide US FDA 1
Tirzepatide US FDA 1

Also appears on these molecule pages

Eptifibatide API Retatrutide API Semaglutide API Tirzepatide API

Questions about Sichuan Jisheng Biopharmaceutical

Does Sichuan Jisheng Biopharmaceutical hold a US DMF or a CEP?
Sichuan Jisheng Biopharmaceutical holds 4 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Sichuan Jisheng Biopharmaceutical FDA-registered?
One site operated by Sichuan Jisheng Biopharmaceutical carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
Where does Sichuan Jisheng Biopharmaceutical manufacture?
1 registered site is on record, in China (China). Every site is listed on this page with the register it came from.
What does Sichuan Jisheng Biopharmaceutical make?
4 molecules are on record against Sichuan Jisheng Biopharmaceutical, including Eptifibatide, Retatrutide, Semaglutide and Tirzepatide. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Sichuan Jisheng Biopharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Hybio Pharmaceutical shares 2 molecules Sinopep-Allsino Biopharmaceutical shares 2 molecules Chengdu Shengnuo Biopharm shares 2 molecules Alp Pharm Beijing shares 1 molecule PolyPeptide shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability